Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bas W G van Rhijn

Showing results (1-10 of 215) with videos related to

Pageof 22
Sort By:
BJU International|May 7, 2011
Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivityBas W G van Rhijn
The Journal of Urology|December 20, 2011
Editorial commentBas W G van Rhijn
Urologic Oncology|June 30, 2012
Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancerBas W G van Rhijn
European Urology|January 29, 2008
Considerations on the use of urine markers for bladder cancerBas W G van Rhijn
Nature Reviews. Urology|September 1, 2016
Bladder cancer: Low adherence to guidelines in non-muscle-invasive diseaseBas W G van Rhijn, Maximilian Burger
Translational Andrology and Urology|October 28, 2016
Genetics and biological markers in urachal cancerMark A Behrendt, Bas W G van Rhijn
BJU International|October 7, 2023
Electronic health record and research; happy marriage or early divorce?Matthijs J Scheltema, Bas W G van Rhijn
European Urology|December 14, 2011
A plea for long-term surveillance in bacillus Calmette-Guérin-treated non-muscle-invasive bladder cancerRichard P Meijer, Bas W G van Rhijn
European Urology|August 9, 2014
The molecular background of urothelial cancer: ready for action?Michiel S van der Heijden, Bas W G van Rhijn
Annals of Surgical Oncology|April 24, 2020
ASO Author Reflections: How to Detect Peritoneal Metastases of Urachal Carcinoma? The Value of Diagnostic Laparoscopy and Abdominal Cytology in Staging This Rare MalignancyLaura E Stokkel, Laura S Mertens, Bas W G van Rhijn
Pageof 22

Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
BJU International|May 7, 2011
Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivityBas W G van Rhijn
The Journal of Urology|December 20, 2011
Editorial commentBas W G van Rhijn
Urologic Oncology|June 30, 2012
Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancerBas W G van Rhijn
European Urology|January 29, 2008
Considerations on the use of urine markers for bladder cancerBas W G van Rhijn
Nature Reviews. Urology|September 1, 2016
Bladder cancer: Low adherence to guidelines in non-muscle-invasive diseaseBas W G van Rhijn, Maximilian Burger
Translational Andrology and Urology|October 28, 2016
Genetics and biological markers in urachal cancerMark A Behrendt, Bas W G van Rhijn
BJU International|October 7, 2023
Electronic health record and research; happy marriage or early divorce?Matthijs J Scheltema, Bas W G van Rhijn
European Urology|December 14, 2011
A plea for long-term surveillance in bacillus Calmette-Guérin-treated non-muscle-invasive bladder cancerRichard P Meijer, Bas W G van Rhijn
European Urology|August 9, 2014
The molecular background of urothelial cancer: ready for action?Michiel S van der Heijden, Bas W G van Rhijn
Annals of Surgical Oncology|April 24, 2020
ASO Author Reflections: How to Detect Peritoneal Metastases of Urachal Carcinoma? The Value of Diagnostic Laparoscopy and Abdominal Cytology in Staging This Rare MalignancyLaura E Stokkel, Laura S Mertens, Bas W G van Rhijn
Pageof 22